Patents by Inventor Anita Dabbara

Anita Dabbara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STABLE FORMULATIONS OF ANTIBODIES TO TSLP
    Publication number: 20140227250
    Abstract: The present invention relates to stable formulations of antibodies against human TSLP, or antigen binding fragments thereof.
    Type: Application
    Filed: August 21, 2013
    Publication date: August 14, 2014
    Applicant: MERCK SHARP & DOHME CORP.
    Inventors: Yunsong Li, Valentyn Antochshuk, Anita Dabbara, Angela Mohs, Alexandre Ambrogelly
  • FORMULATION CONTAINING CYCLIN-DEPENDENT KINASE INHIBITING COMPOUND AND METHOD OF TREATING TUMORS USING THE SAME
    Publication number: 20100286038
    Abstract: This application discloses a novel formulation containing a 3-amino-4-substituted pyrazole derivative which has cyclin-dependent kinase inhibiting properties, and a method of treating tumors using the novel formulation.
    Type: Application
    Filed: September 16, 2008
    Publication date: November 11, 2010
    Inventors: Valentyn Antochshuk, Anita Dabbara, Paul Kirschmeier, David A. Parry, Mohammed Shameen, Siu-Long Yao
  • Stable pegylated interferon formulation
    Patent number: 7632491
    Abstract: The present invention relates to lyophilized formulations of pegylated interferon which are prepared using trehalose as a cryoprotectant. The formulations have a low moisture content, which helps stabilize the pegylated interferon during storage of the formulations at room temperature. In addition, methods for preparing these formulations are provided.
    Type: Grant
    Filed: August 11, 2005
    Date of Patent: December 15, 2009
    Assignee: Schering Corporation
    Inventors: Mohammed Shameem, Anita Dabbara
  • Stable pegylated interferon formulation
    Publication number: 20060051320
    Abstract: The present invention relates to lyophilized formulations of pegylated interferon which are prepared using trehalose as a cryoprotectant. The formulations have a low moisture content, which helps stabilize the pegylated interferon during storage of the formulations at room temperature. In addition, methods for preparing these formulations are provided.
    Type: Application
    Filed: August 11, 2005
    Publication date: March 9, 2006
    Inventors: Mohammed Shameem, Anita Dabbara